Curcumin, a polyphenol extracted from Curcuma longa, also known as turmeric, has gained attention from scientists worldwide for its biological properties as an antioxidant, anti-inflammatory, antimicrobial, and antiviral agent.
In addition, curcumin’s anticancer potential has been the most described and still remains under investigation.
In a new review study, researchers discussed the most significant research findings.
The research was conducted by a team at Temple University in Philadelphia and elsewhere.
In the last year, many scientists have discussed the real health benefits of Curcumin, often stimulating very passionate debate.
As scientists involved in studies related to natural compounds and cancer, the team wanted to explore the most recent findings on this topic.
The review has collected studies concerning the anticancer potential of curcumin against the most widespread cancers and also describing the molecular mechanisms of action.
Moreover, the problem of bioavailability of curcumin, as well as the most recent advances in the clinical use of curcumin and new drug formulations, are discussed.
The authors conclude that thanks to its effects on different signaling pathways and molecular targets involved in the development of several cancers, curcumin represents a promising candidate as an effective anticancer drug, either alone or in combination with other treatments.
The lead author of the study is Prof. Antonio Giordano, M.D., Ph.D., Founder, and Director of the Sbarro Health Research Organization and the Sbarro Institute for Molecular Medicine and Cancer Research.
The study is published in Nutrients.
Copyright © 2019 Knowridge Science Report. All rights reserved.
